[Duchenne Boulogne myopathy and free radicals; potential value of lazaroids in the treatment of this disease].
Poindron
P
P
Département d'Immunologie, Immunopharmacologie et Pathologie, Université Louis Pasteur, Illkirch.
Metzinger
L
L
Warter
J M
JM
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use*; D002460:Cell Line; D004195:Disease Models, Animal; D016189:Dystrophin / Q000378:metabolism; D005609:Free Radicals / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D008810:Mice, Inbred C57BL; D018482:Muscle, Skeletal / Q000166:cytology / Q000187:drug effects / Q000196:embryology; D009136:Muscular Dystrophies / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism*; D009137:Muscular Dystrophy, Animal / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism; D011281:Pregnatrienes / Q000494:pharmacology / Q000627:therapeutic use*
D000975:Antioxidants; D016189:Dystrophin; D005609:Free Radicals; D011281:Pregnatrienes
Myopathie de Duchenne de Boulogne et radicaux libres; intérêt potentiel des lazaroïdes dans le traitement de cette maladie.